Nuveen Asset Management, LLC Harrow Health, Inc. Transaction History
Nuveen Asset Management, LLC
- $329 Billion
- Q1 2024
A detailed history of Nuveen Asset Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 109,083 shares of HROW stock, worth $2.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,083
Previous 221,843
50.83%
Holding current value
$2.36 Million
Previous $2.48 Million
41.91%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HROW
# of Institutions
124Shares Held
21.3MCall Options Held
113KPut Options Held
366K-
Opaleye Management Inc. Boston, MA3.92MShares$84.7 Million12.62% of portfolio
-
Private Capital Management, LLC Naples, FL3.01MShares$65.1 Million4.93% of portfolio
-
Black Rock Inc. New York, NY2.18MShares$47.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$39.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY953KShares$20.6 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $585M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...